BioLineRx Ltd.
BLRX
Sync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, BioLineRx Ltd. shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
11-Year Financial Trajectory
Annualinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2021 20-F ↗ | FY 2020 Dec 31, 2020 20-F ↗ | FY 2019 Dec 31, 2019 20-F ↗ | FY 2018 Dec 31, 2018 20-F ↗ | FY 2017 Dec 31, 2017 20-F ↗ | FY 2016 Dec 31, 2016 20-F ↗ | FY 2015 Dec 31, 2015 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth YoY (%) |
78.0%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
84.8%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-142.9%
Weak
↓
Weak
Declining
Year-over-year change in net income |
7.8%
Fair
↑
Fair
Improving
Year-over-year change in net income |
9.9%
Fair
↑
Fair
Improving
Year-over-year change in net income |
-18.0%
Weak
↑
Weak
Improving
Year-over-year change in net income |
-10.8%
Weak
↑
Weak
Improving
Year-over-year change in net income |
5.7%
Fair
↑
Fair
Improving
Year-over-year change in net income |
-53.7%
Weak
Weak
Year-over-year change in net income |
-10.0%
Weak
Weak
Year-over-year change in net income |
— |
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2021 20-F ↗ | FY 2020 Dec 31, 2020 20-F ↗ | FY 2019 Dec 31, 2019 20-F ↗ | FY 2018 Dec 31, 2018 20-F ↗ | FY 2017 Dec 31, 2017 20-F ↗ | FY 2016 Dec 31, 2016 20-F ↗ | FY 2015 Dec 31, 2015 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-2.03M | $-9.22M | $-60.61M | $-24.95M | $-27.05M | $-30.02M | $-25.45M | $-22.96M | $-24.35M | $-15.84M | $-14.40M |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare BLRX with peers
Stack BLRX against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced yesterday 11 years · 10 quarters